A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2006
11/28/2006	CA2379786C Purine derivatives
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2378007C Benzimidazole compounds
11/28/2006	CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/28/2006	CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006	CA2314775C Novel lactic acid bacterial preparation that reduces triglycerides and cholesterol
11/28/2006	CA2301185C Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
11/28/2006	CA2216320C Stable emulsions and dry powders of mixtures of fat-soluble vitamins, their preparation and use
11/28/2006	CA2208095C Generation of human insulin
11/28/2006	CA2137203C Protein kinase c inhibitors
11/27/2006	CA2547845A1 Amniotic fluid derived cells
11/23/2006	WO2006125180A1 Piperazine derivatives and their uses as therapeutic agents
11/23/2006	WO2006125179A1 Tricyclic compounds and their uses as therapeutic agents
11/23/2006	WO2006124529A1 Glp-1 pegylated compounds
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006123724A1 Novel pharmaceutical using anti-hla antibody
11/23/2006	WO2006123618A1 Oxidative stress inhibitor
11/23/2006	WO2006123466A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006122931A1 Beta-carboline derivatives and theri use as ghsr modulators
11/23/2006	WO2006122485A1 A pharmaceutical composition for treating diabetes and process thereof
11/23/2006	WO2006122454A1 A pharmaceutical composition for treating diabetes and preparation method thereof
11/23/2006	WO2006122363A1 Therapeutic agents and targets
11/23/2006	WO2006084757A3 Combination of ca/mg salt of valsartan with an antidiabetic agent
11/23/2006	WO2006084015A3 Raf inhibitor compounds and methods
11/23/2006	WO2006076317A3 Aminophenyl derivatives as selective androgen receptor modulators
11/23/2006	WO2006071762A3 Pyrimidine-based inhibitors of dipeptidyl peptidase iv and methods
11/23/2006	WO2006071538A3 Substituted biaryl analogues
11/23/2006	US20060264639 crystalline rosiglitazone maleate filtration
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE
11/23/2006	US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006	US20060264498 Anti-obesity agent
11/23/2006	US20060264494 Heterocyclic amide derivatives which process glycogen phorylase inhibitory activity
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264436 Method of Treating a Psychotic Disorder
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006	US20060264418 6-(2,2,2-Trifluoroethylamino-7-chloro-2,3,4,5-tetrahydro-1h-benzo[d] azephine as a 5-ht2c receptor agonist
11/23/2006	US20060263881 Methods of expanding and selecting disease associated T-Cells
11/23/2006	US20060263849 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo
11/23/2006	US20060263408 Implantable medical device seeded with mammalian cells and methods of treatment
11/23/2006	DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006	CA2608957A1 Pyrrolidine derivative or salt thereof
11/23/2006	CA2608447A1 Oxidative stress inhibitor
11/23/2006	CA2608405A1 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
11/22/2006	EP1724284A2 GLP-1 fusion proteins
11/22/2006	EP1724278A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
11/22/2006	EP1724277A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1723960A1 Botanical compositions having oral insulin-like hypoglycemic activity, with hypolipidemic and antimicrobial activities
11/22/2006	EP1723954A1 Indazole derivatives for the treatment of cancer
11/22/2006	EP1723953A1 Nutritional supplements
11/22/2006	EP1723948A1 Controlled release compositions of biguanide with less side effects and treatment regimen thereof
11/22/2006	EP1723854A1 Beverage or drug containing bamboo extract as main ingredient
11/22/2006	EP1723128A1 Heteroaryl-ureas and their use as glucokinase activators
11/22/2006	EP1723126A2 Novel mch receptor antagonists
11/22/2006	EP1723120A1 Ion channel modulators
11/22/2006	EP1722801A1 Use of enhanced water to improve blood sugar management
11/22/2006	EP1722787A1 Ion channel modulators
11/22/2006	EP1722778A1 Methods and compositions for the treatment of lipodystrophy
11/22/2006	EP1722770A1 Use of metformin and orlistat for the treatment of prevention of obesity
11/22/2006	EP1651644B1 Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
11/22/2006	EP1551860B1 Glucocorticoid receptor ligands for the treatment of metabolic disorders
11/22/2006	EP1501815B1 Substituted phenylacetamides and their use as glucokinase activators
11/22/2006	EP1497291B1 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
11/22/2006	EP1492553B1 Cg8327 and srm involved in the regulation of energy homeostasis
11/22/2006	EP1483271B1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
11/22/2006	EP1483265B1 Purine derivatives as kinase inhibitors
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1461034B1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
11/22/2006	EP1458721B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/22/2006	EP1458683B1 Heteroaryl-substituted aminocyclohexane derivatives
11/22/2006	EP1427717B1 Bioprecursors for percutaneous application
11/22/2006	EP1399156B1 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1315482B1 Water-dispersible encapsulated sterols
11/22/2006	EP1301475B1 Aryl sulfonamides as serotonin antagonist for the treatment of obesity
11/22/2006	EP1294757B1 Glucagon-like peptide-1 analogs
11/22/2006	EP1268435B1 4,5-dihydro-1h-pyrazole derivatives having cb 1-antagonistic activity
11/22/2006	EP1194777B1 Methods and compositions relating to pancreatic islet and beta-cell dysfunction
11/22/2006	EP1000158B1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
11/22/2006	EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867351A Remedy for kidney diseases
11/22/2006	CN1867325A Jelly pharmaceutical preparation containing biguanide-based medicine
11/22/2006	CN1865450A Fatty acid extract of Antrodiacamphorata mycelium and its uses
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1864743A Methods for the treatment of insulin resistance and disease states characterized by insulin resistance
11/22/2006	CN1864731A Anti-thrombosis blood fat-reducing blood pressure-decreasing oral liquid
11/22/2006	CN1864708A Blood sugar-decreasing health food
11/22/2006	CN1864705A An arctium fruit extract, its preparation method and application
11/22/2006	CN1864699A Novel dosage form of multiple Vitamins
11/22/2006	CN1864673A A levo-carnitine for injection and preparation method thereof
11/22/2006	CN1864663A Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2 (11),3,5,7,9-pentaene
11/22/2006	CN1864547A A tea mixed coffee with glossy ganoderma and method for preparing same
11/22/2006	CN1864546A A Chinese wolfberry cake and preparation process thereof
11/22/2006	CN1864542A Organic potassium supplementation preparation made from compound Chinese herbs for hypertension control
11/22/2006	CN1864541A Fat-reducing food with black fungus and method for processing same

1 ... 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 ... 1298